Lynsey Bennett fears upcoming scan results may leave her with no further cancer treatment
Lynsey Bennett has been receiving the immunotherapy drug Pembrolizumab. Picture: Collins Courts
Mother-of-two Lynsey Bennett says she has “bad nerves” ahead of her next round of cancer treatment, as a routine scan will determine whether she can continue receiving the immunotherapy drug Pembrolizumab.
In June, Bennett learned she developed a clot on her lung. She said at the time that the clot “doesn't even matter” because she had seen a significant reduction in a tumour since starting Pembro.
